C5851

CGP 35348 hydrate

≥97% (NMR), solid

• Synonyma: (3-Aminopropyl)(diethoxymethyl)phosphinic acid hydrate
• Empirický vzorec (Hillův zápis): C₈H₂₀NO₄P · xH₂O
• Číslo CAS: 123690-79-9
• Molekulová hmotnost: 225.22 (anhydrous basis)
• MDL number: MFCD11045877
• UNSPSC Code: 12352200
• PubChem Substance ID: 329775103
• NACRES: NA.77

Vlastnosti

• assay: ≥97% (NMR)
• form: solid
• storage condition: desiccated
• color: white
• solubility: H₂O: >20 mg/mL
• originator: Novartis
• storage temp.: −20°C
• SMILES string: O.CCOC(OCC)P(O)(=O)CCCN
• InChI: 1S/C8H20NO4P.H2O/c1-3-12-8(13-4-2)14(10,11)7-5-6-9;/h8H,3-7,9H2,1-2H3,(H,10,11);1H2
• InChI key: SRBHGEXMDCJOMS-UHFFFAOYSA-N

Popis

Application

CGP 35348 hydrate has been used as a γ-aminobutyric acid-B (GABA_B) receptor inhibitor:

• to study its effects on intrinsic optical signal (IOS) in rat hippocampus
• alone or in combination with sodium salicylate to study its effects on auditory responses in the rat′s dorsal cortex of rat
• to study its effects on hepatocellular carcinoma cells (HCC)

Biochem/physiol Actions

CGP 35348 is a γ-aminobutyric acid-B (GABA_B) receptor antagonist. It has a higher affinity towards post-versus presynaptic receptors that can penetrate the blood-brain barrier.

Features and Benefits

This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound is featured on the GABAB Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Caution

Product is hygroscopic

Bezpečnostní informace

• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)